TNL Mediagene gets Nasdaq bid-price notice; hearing may allow 180 days
Rhea-AI Filing Summary
TNL Mediagene reported it received a Nasdaq staff determination letter stating it did not regain compliance with Nasdaq Listing Rule 5550(a)(2), which requires a minimum bid price of $1.00 per share by November 3, 2025, and is not eligible for a second 180-day grace period.
The letter has no immediate effect on the company’s Nasdaq Capital Market listing. The company intends to request a hearing, which will automatically stay any suspension or delisting action pending the hearing and any extension granted. Under Nasdaq rules, a Hearing Panel may grant an extension not to exceed 180 days from the date of the determination letter.
Positive
- None.
Negative
- None.
Insights
Nasdaq bid-price noncompliance disclosed; hearing to stay delisting.
TNL Mediagene disclosed a staff determination for not meeting the $1.00 minimum bid price by November 3, 2025. The notice itself does not remove the listing and triggers a procedural path to seek continued listing.
The company plans to request a hearing, which automatically stays suspension or delisting. A Nasdaq Panel may grant up to 180 days from the letter date. Actual outcomes depend on the Panel’s decision and the company’s ability to meet the rule within any extension.
Key items to track are the scheduling of the hearing and any Panel extension length. Subsequent company disclosures may provide timing and any actions taken to restore compliance.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did TNMG disclose in the latest 6-K?
Does the determination letter immediately affect TNMG’s Nasdaq listing?
What steps will TNMG take following the determination letter?
How long an extension can the Nasdaq Panel grant?
Which Nasdaq rule is at issue for TNMG?
AI-generated analysis. How Rhea-AI works. Not financial advice.